Back to Search
Start Over
Adverse Reactions to Biologics: Melanoma (Ipilimumab, Nivolumab, Pembrolizumab).
- Source :
- Current Problems in Dermatology; 2017, Vol. 53, p82-92, 11p
- Publication Year :
- 2017
Details
- Language :
- English
- ISSN :
- 14215721
- Volume :
- 53
- Database :
- Complementary Index
- Journal :
- Current Problems in Dermatology
- Publication Type :
- Academic Journal
- Accession number :
- 126175875
- Full Text :
- https://doi.org/10.1159/000478081